StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Moderna (MRNA), BioNTech (BNTX) Trade to High as Study Show Reduced Protection of Current Vaccine vs Omicron
December 7, 2021 3:30 PM
Moderna (NASDAQ: MRNA), BioNTech SE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Moderna (MRNA) Will Host Conference Call on Phase 1 Interim Analysis for mRNA Flu Vaccine on Friday, December 10
December 9, 2021 4:44 PM
BioNTech SE (BNTX) to Hold Digital Press Conference on December 8, 2021 at 9AM ET to Provide an Update on Omicron Variant
December 8, 2021 7:16 AM
Study Shows 40-Fold Reduction in Neutralization Capacity of Pfizer (PFE) Vaccines Vs Omicron - DJ
December 7, 2021 3:21 PM
Africa Health's Sigal: Omicron Pfizer Immune Escape Incomplete - Bloomberg
December 7, 2021 3:14 PM